2025 annual financial data
Oruka Therapeutics 2025 Operating margin
Oruka Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -122,051,000 USD and net income was -105,433,000 USD.
Operating cash flow was -88,210,000 USD.
Get free Oruka Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -122,051,000 USD
- Net income
- -105,433,000 USD
- Operating cash flow
- -88,210,000 USD